MaaT Pharma’s microbiome therapy scores phase 3 win
Shares of the French biotech were up by almost 18% following the announcement of positive trial results for its graft-versus-host disease treatment.
Archives for January 9, 2025
Alchemab and Lilly collaborate to discover and develop ALS therapies
Together, the companies will work on up to five novel ALS antibody therapeutics.